explore -WSS

explore

author：comprehensive 2025-10-01 18:44:49 - browse：1

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear.

The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. Morgan Healthcare Conference, and describing why it thinks AI, running on Nvidia computers, could dramatically increase the number of new medicines that are created while reducing their cost, ushering in an age of “digital biology.”

When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： First U.S. drug developed to treat liver disease MASH is approved

WSS

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

New chart reveals military’s vast involvement in Operation Warp Speed

WuXi out of biotech trade group, U.S. and China relations to blame

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

President Biden's budget: Here's what you might have missed

focus

explore

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Supreme Court strikes down use of affirmative action

Ebola: Gilead Sciences antiviral shows promise as new treatment

Duchenne breakthrough therapy leaves behind pioneering families

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

As demand for Covid shots wanes, Moderna seeks its next success

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Apple is now the first public company to be valued at $3 trillion

Male and female sex labels in research insufficient, scientists say

explore

EPA limits use of carcinogenic gas for sterilizing medical devices

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

President Biden's budget: Here's what you might have missed

Male and female sex labels in research insufficient, scientists say

First U.S. drug developed to treat liver disease MASH is approved

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

leisure time

focus

hotspot

entertainment